Lawrence Gozlan
Patrimonio netto: 46 362 $ in data 31/08/2026
Patrimonio netto: 46 362 $ in data 31/08/2026
Mr. Lawrence B. Gozlan is an Independent Non-Executive Director at Ceryvyn Therapeutics Ltd., a Chairman at Enlitic, Inc., a Manager-Life Sciences Investment at Jagen Pty Ltd. and a Chief Investment Officer at Scientia Capital Pty Ltd. He is on the Board of Directors at Ceryvyn Therapeutics Ltd., AusBiotech Ltd., Alterity Therapeutics Ltd. and Faraday Pharmaceuticals, Inc. (Washington).
Mr. Gozlan was previously employed as a Chairman by Phosphagenics Ltd., an Independent Non-Executive Director by OncoSil Medical Ltd., a Non-Executive Director by Telesso Technologies Ltd., a Non-Executive Director by Nohla Therapeutics, Inc., and a Non-Executive Director by Novita Healthcare Ltd. He received his undergraduate degree from the University of Melbourne.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/08/2026 | 90.910 ( 0,04% ) | 32 901 $ | 31/08/2026 | |
| 19/12/2025 | 1.877.357 ( 0,14% ) | 13 461 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 08/08/2011 |
| CERYVYN THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 24/07/2020 |
| ENLITICGDS | Presidente | - |
Scientia Capital Pty Ltd.
Scientia Capital Pty Ltd. Investment ManagersFinance Scientia Capital focuses exclusively in life sciences sector. | Amministratore Delegato | - |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Direttore/Membro del Consiglio | 01/02/2013 |
Faraday Pharmaceuticals, Inc. (Washington)
Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Develops small molecule drugs | Direttore/Membro del Consiglio | - |
Jagen Pty Ltd.
Jagen Pty Ltd. Investment ManagersFinance Jagen invests in companies located in Australia. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. | Corporate Officer/Principal | 01/01/2007 |
| Società | Posizione | Fine |
|---|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Presidente | 12/05/2015 |
| ONCOSIL MEDICAL LIMITED | Direttore/Membro del Consiglio | 04/05/2015 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Avecho Biotechnology Ltd.
Avecho Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical and nutraceutical products | Health Technology |
Faraday Pharmaceuticals, Inc. (Washington)
Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Develops small molecule drugs | Retail Trade |
Opthea Ltd.
Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Telesso Technologies Ltd.
Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology research and development company | Health Technology |
Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tali Digital Ltd.
Tali Digital Ltd. Packaged SoftwareTechnology Services Discovers and develops anti-infective pharmaceutical medicines | Technology Services |
OncoSil Medical Ltd.
OncoSil Medical Ltd. Medical SpecialtiesHealth Technology Develops and commercializes neurology services including those for pancreatic cancer | Health Technology |
Scientia Capital Pty Ltd.
Scientia Capital Pty Ltd. Investment ManagersFinance Scientia Capital focuses exclusively in life sciences sector. | Finance |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Jagen Pty Ltd.
Jagen Pty Ltd. Investment ManagersFinance Jagen invests in companies located in Australia. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. | Finance |
Enlitic, Inc.
Enlitic, Inc. Packaged SoftwareTechnology Services Builds AI software products to streamline radiologists, workflows and improve healthcare diagnosis | Technology Services |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale